Task Force Information
Objectives
The Probiotics Task Force advances understanding of how probiotics influence human health and disease, with particular attention to their mechanisms of action and potential health benefits. To do so, strengthening the scientific evidence behind both their direct and indirect effects on human health is key.
Why It Matters
For public health, stronger evidence on probiotic effects supports evidence-based use and informed consumer choices, helping ensure that products intended to support health are safe, effective and appropriately communicated.
For companies, robust mechanistic and clinical evidence helps identify promising probiotic solutions, guide product development and substantiate health benefits, enabling credible products that respond to consumer needs and build consumer trust.
Task Force Members
| Arthur Ouwehand – Chair | International Flavors & Fragrances (IFF) | R&D Group Manager | FI |
| Geertrui Vlaemynck* – Co-Chair | Institute for Agricultural and Fisheries Research (ILVO) | Scientific Director | BE |
| Bruno Pot | Yakult Europe | Science Director Europe | NL |
| Jonathan Lane | H&H Group | Senior Manager, Global Research | IE |
| David Perez Pascual | Danone Nutricia Research | Team Leader Culture Collection | FR |
| Delphine Saulnier | Novonesis | Science Manager | DE |
| Benjamin Anderschou Holbech Jensen* | University of Copenhagen | Assist. Professor, Head of Nutritional Immunology | DK |
| Erinn Quinn | Holland & Barrett | Senior Scientist | UK |
| Vicenta Garcia Campayo | Cargill | Principal Scientist | USA |
| Olaf Larsen | Ausnutria | Research Manager | NL |
* Scientific Advisors
Contact Information
For more detailed information, please contact Isabelle Guelinckx at iguelinckx@ilsieurope.be
Activity Overview
Ongoing Activities
- Markers of the Gut Microbiota
The group aims to identify key markers for assessing microbiota improvement, focusing on measurable indicators of microbiota composition and activity that are relevant to human health. This activity will address the need for standardized markers to evaluate dietary interventions, combining various indicators for comprehensive evaluation. The activity is shared with the Prebiotics Task Force.
Start date: 2025 - End date: 2026
- Postbiotics for early life nutrition
The Expert group aims to explore the emerging role of postbiotics in infant nutrition through a focused, workshop-style debate involving experts in microbiota, pediatrics, and nutritional science. This initiative will identify key challenges, assess knowledge gaps, and develop recommendations to guide future research and applications. The outcomes will be published to support evidence-based guidance in infant and early childhood health. This is a joint activity with the Early Nutrition and Long-Term Health Task Force.
Start date: 2025 - End date: 2027
In the Pipeline
- Microbiome and healthy ageing: exploring how the gut microbiome may influence healthy ageing and identifying key research gaps (in collaboration with the Healthy Ageing Task Force).
Expert Groups
Markers of the Gut Microbiota
Background and Objectives
Changes in the gut microbiota are increasingly linked to health outcomes, but consistent markers for measuring these effects are still lacking. This Expert Group aims to establish standardized markers for assessing improvements in gut microbiota composition and activity following dietary interventions. They are evaluating microbial composition, metabolites, enzymatic systems, mucosal integrity and immune responses to identify the most informative and predictive parameters for human health and strengthen the evidence linking prebiotic-induced microbiota changes to health benefits.
Output
Open-access peer-reviewed publication.
Expert Group Members
| Sofia Forssten | IFF | Lead Scientist | FI |
| Damien Guillemet | Nexira | Science Development Director | FR |
| Alexandra Meynier | Mondelēz International | Nutrition Scientist | FR |
| Clementine Thabuis | Roquette | Senior Nutrition & Health Research Manager | FR |
| Delphine Saulnier | Novonesis | Global Health Category Science & Technology Lead | DK |
| Sahar El Aidy | University of Amsterdam | Professor of Microbiome Engineering | NL |
| Renate Akkerman | Maastricht University | Assitant Professor of Sustainable Foods and Health | NL |
| Paul de Vos | Maastrich University | Professor of Sustainable Foods and Immunity | NL |
| Kristin Verbeke | KU Leuven | Researcher and Professor | BE |
| Anisha Wijeyesekera | University of Reading | Associate Professor of Microbiome and Metabolome Studies | UK |
| Holly Sedgwick | University of Reading | PhD Candidate | UK |
| Jonathan Swann | University of Southampton | Professor of Biomolecular Medicine | UK |
Postbiotics for Early Life Nutrition
Background and Objectives
The amount of scientific literature on postbiotics, as well as the term ‘postbiotics’ on commercial products is rapidly rising. The purpose of this activity is to bring together diverse expertise to address the multifaceted challenges and considerations associated with adding postbiotics to infant and toddler nutrition. This will include experts in microbiology, nutrition, paediatrics, immunology, food science, regulation and clinical research. Key objectives would be to list and discuss considerations around safety and efficacy, regulatory, characterization and formulation challenges, clinical trial design and reporting, consumer education. Additionally, to discuss the existence of ‘natural’ postbiotics in human milk as well as toddler fermented food.
Output
Review of the current literature + Physical workshop (September 2026) & its proceedings.
Expert Group Members
| Janna van Diepen | Reckitt / Mead Johnson Nutrition | Principal Scientist | NL |
| Renaud Mestdagh | DSM-Firmenich | Senior Scientist | BE |
| Karen Knipping | Ausnutria | Research Scientist Immunology | NL |
| Kirsten Szklany | Yili Innovation Center Europe | Scientist in Nutrition and Innovation | NL |
| Raish Oozer | Danone Nutricia Research | Research and Innovation Director | NL |
| Benjamin A. H. Jensen | University of Copenhagen | Associate Professor in Nutritional Immunology | DK |
| Mehreen Anjum | IFF | Platform Innovation Leader | FI |
| Anja Wellejus | Novonesis | Senior Manager | DK |
| Elena Oliveros | Abbott | Research Scientist | ES |
| Hania Szajewska | Medical University of Warsaw | Professor and Chair of the Department of Paediatrics | PL |
| Simone Guglielmetti | Universita degli Studi di Milano-Bicocca | Professor | IT |
| Clara Belzer | Wageningen University & Research | Professor | NL |
| Seppo Salminen | University of Turku | Professor | FI |
| Karti Korpela | University of Helsinki | Associate Professor | FI |
| Sandra Einerhand | Einerhand Science & Innovation | Nutrition Consultant | NL |
| Ellen GHM van den Heuvel | LLN NutriResearch | Nutrition Consultant | NL |
| Alie de Boer | Maastricht University | Associate Professor | NL |
Publications
Journal Articles
Guidance for Assessing the Probiotics Beneficial Effects: How to Fill the Gap
2010
Multimedia
Task Force Work in the Media
- Agro Food Industry Hi-Tech: Probiotic Human Study Design and Reporting (PRODARE): improving probiotic research (August 2026)
- NutraIngredients Europe: ILSI Europe outlines framework to boost impact of human probiotic studies (July 2026)
Completed Expert Groups
- Benefits, challenges, and opportunities with changes in the maternal microbiome before and during pregnancy
- Prediction of individual responses to prebiotics and probiotics intervention (collaboration Prebiotics Task Force)
- Joint nutrition cluster activity on ‘mechanistic insights into the gut-brain axis' in collaboration with Early Nutrition and Long-Term Health; Health Benefit Assessment of Foods; Nutrition, Immunity & Inflammation; Nutrition & Brain Health and Prebiotics Task Forces
- Updated concise monograph - Dietary Probiotics, Prebiotics and the Gut Microbiota in Human Health (collaboration with Probiotics Task Force)